Utilidad de los test de resistencias del VIH en la práctica clínica. Indicaciones en el medio penitenciario

作者: J García-Guerrero

DOI:

关键词:

摘要: The objective of this study is to revise the usefulness and management penitentiary clinical practice genotypic phenotypic tests. Genotypic tests establish types mutations that appear in HIV genome area are involved resistance development. Phenotypic measure susceptibility a given viral strain FARV presence decreasing concentrations drug question. material published on subject reviewed study. In daily practice, have become an extremely useful tool for establishing treatment amongst positive patients, especially cases therapeutic failure require change treatment. Generally speaking it strongly recommended therapy be carried out patients with two or more previous failures, pregnant women infected children. Individual testing establishment initial acute/recent infection individual accidental post-exposure prophylaxis. It is, however, not at beginning chronic infection. Key words: HIV. Drug Resistance. Prisons.

参考文章(33)
Patrizio Lorenzi, Milos Opravil, Bernard Hirschel, Jean-Philippe Chave, Hans-Jacob Furrer, Hugo Sax, Thomas Vaclav Perneger, Luc Perrin, Laurent Kaiser, Sabine Yerly, Swiss HIV Cohort Study, Impact of drug resistance mutations on virologic response to salvage therapy AIDS. ,vol. 13, ,(1999) , 10.1097/00002030-199902040-00001
Alejo Erice Calvo-Sotelo, Santiago Moreno Guillén, José María Gatell Artigas, Resistencia del VIH a los fármacos antirretrovirales ,(1999)
P. Halfon, P. Dellamonica, J. M. Schapiro, J. Durant, V. Mondain, C. A. B. Boucher, P. Clevenbergh, N. Montagne, P. del Giudice, Persisting long-term benefit of genotype-guided treatment for HIV-infected patients failing HAART. The Viradapt Study: week 48 follow-up. Antiviral Therapy. ,vol. 5, pp. 65- 70 ,(2000)
Daniel R. Kuritzkes, John W. Mellors, Bonaventura Clotet, Lisa M. Demeter, Donna M. Jacobsen, Douglas D. Richman, Clive Loveday, Scott M. Hammer, Victoria A. Johnson, Stefano Vella, Brian Conway, Martin S. Hirsch, Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection ,(2000)
John D Schuetz, Michele C Connelly, Daxi Sun, Sheela G Paibir, Patricia M Flynn, RV Srinivas, Alok Kumar, Arnold Fridland, None, MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs. Nature Medicine. ,vol. 5, pp. 1048- 1051 ,(1999) , 10.1038/12487
K Hertogs, Alessandro Cozzi-Lepri, P Gute, H Rabenau, Andrew Phillips, S Bloor, S Staszewski, B Larder, S Klauke, Miller, HIV drug susceptibility and treatment response to mega-HAART regimen in patients from the Frankfurt HIV cohort. Antiviral Therapy. ,vol. 5, pp. 49- 55 ,(2000)
G. Angarano, L. Monno, A. Appice, A. Giannelli, C. Romanelli, C. Fico, G. Pastore, TRANSMISSION OF ZIDOVUDINE-RESISTANT HIV-1 THROUGH HETEROSEXUAL CONTACTS AIDS. ,vol. 8, pp. 1013- 1014 ,(1994) , 10.1097/00002030-199407000-00023
Helen L. Devereux, Mike Youle, Margaret A. Johnson, Clive Loveday, Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy AIDS. ,vol. 13, pp. 123- 127 ,(1999) , 10.1097/00002030-199912240-00001
Teresa Puig, Mayte Pérez-Olmeda, Amalia Rubio, Lidia Ruiz, Carlos Briones, José M Franco, María Gómez-Cano, Lieven Stuyver, Laura Zamora, Camilo Alvarez, Manolo Leal, Bonaventura Clotet, Vicente Soriano, ERASE-2 Study Group, None, Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain. AIDS. ,vol. 14, pp. 727- 732 ,(2000) , 10.1097/00002030-200004140-00012
Ma Jesús Pérez-Elías, Randall Lanier, Vicente Muñoz, Isabel Garcia-Arata, Jose L Casado, Paloma Marti-Belda, Ana Moreno, Fernando Dronda, Antonio Antela, Santiago Marco, Santiago Moreno, None, Phenotypic testing predicts virological response in successive protease inhibitor-based regimens. AIDS. ,vol. 14, ,(2000) , 10.1097/00002030-200006160-00002